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Background: In trials of behavioural interventions, the individuals who deliver the intervention are in a position
of key influence on the success of the trial. Their fidelity to the intervention is crucial. Yet little is understood about
the experiences of this group of trial personnel. This study aimed to investigate the views and experiences of
educators who delivered a structured education intervention to people with type 2 diabetes, which incorporated
training in self-monitoring of either blood glucose (SMBG) or urine glucose (SMUG) as part of a randomized
controlled trial (RCT).
Methods: Educators’ views were explored through focus groups before and after training (N = 18) and
approximately 1 year into the trial (N = 14), and semi-structured telephone interviews at approximately 2 years
(N = 7). Analysis was based on the constant comparative method.
Results: Educators held preferences regarding the intervention variants; thus, they were not in individual equipoise.
Training raised awareness of preferences and their potential to impact on delivery. Educators were confident in
their unbiased delivery, but acknowledged the challenges involved. Concealing their preferences was helped by a
sense of professionalism, the patient-centred nature of the intervention, and concessions in the trial protocol
(enabling participants to swap monitoring methods if needed). Commitment to unbiased delivery was explained
through a desire for evidence-based knowledge in the contentious area of SMBG.
Conclusions: The findings provide insight into a previously unexplored group of trial personnel - intervention
deliverers in trials of behavioural interventions - which will be useful to those designing and running similar trials.
Rather than individual equipoise, it is intervention deliverers’ awareness of personal preferences and their potential
impact on the trial outcome that facilitates unbiased delivery. Further, awareness of community equipoise, the need
for evidence, and relevance to the individual enhance commitment to the RCT.
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Equipoise can be defined as genuine uncertainty within
the expert medical community regarding the compara-
tive therapeutic merits of each arm in a trial [1]. A grow-
ing literature has demonstrated that trial participants
have difficulties making sense of randomized controlled
trial (RCT) procedures, random allocation and the
principle of equipoise, and tend to hold preferences for
certain treatment arms [2-7]. Clinician-researchers’ views
also indicate varied levels of understanding of equipoise
[8,9]. However, little is known about the views and expe-
riences of those who deliver interventions in the RCT
context (‘deliverers’), despite their influential position on
participants’ adherence to the intervention and thus the
outcome of the RCT.
In RCTs of pharmaceutical interventions, achieving
equivalence in the delivery of the different arms is rela-
tively straightforward; in a double-blind RCT, using a
placebo that appears identical to a drug can reduce the
potential for bias [10,11]. With interventions that cannot
be blinded (for example, because the intervention cannot
be disguised), minimizing variation in delivery presents
more of a challenge [12,13]. This difficulty increases with
the complexity of the intervention [14]. Randomized
controlled trials of health and lifestyle educational
interventions typically require an individual or team of
individuals for delivery. These deliverers introduce the
potential for variation in delivery, and thus a potential
impact on trial outcomes [15,16].
Variation arising from different levels of skill and
experience of deliverers can be reduced, to some extent,
through training, and assessed through observation or
recording of delivery [15,16]. Variation in deliverers’
behaviour, attitudes and beliefs, and the potential for
these to distort the intervention delivery, are harder to
address [17]. Furthermore, in a trial of two or more
variants of a behavioural intervention, these must all be
delivered in the same unbiased manner [15]. This raises
the question of whether deliverers should be in a state of
individual equipoise, that is, genuine uncertainty on their
part regarding the comparative therapeutic merits of
each arm in a RCT [1], or whether awareness of their
own views is sufficient to avoid bringing bias to their
delivery.
In this article, we explore the accounts of individuals
delivering two variants of a structured education
intervention as part of a multi-site cluster-randomized
controlled trial. Of relevance is that one of the trial arms,
which is education about, and training in, self-monitoring
of blood glucose (SMBG) for self-management of type 2
diabetes, is the subject of much (and often emotive)
debate; clinicians, nurses and patients have strong
opinions on the matter; and thus, little individual equi-
poise (as demonstrated by a recent point-counterpointfeature in the journal Diabetes Care [18,19]). Furthermore,
questions about the funding and cost-effectiveness of
SMBG testing strips fuels the contentiousness of the
debate and the strength of opinion [20]. We first situate
our data in relation to two relevant areas of literature: role
conflict and equipoise.
Role conflict
The usual personnel involved in delivering, and communi-
cating with participants in, clinical trials are doctors,
nurses and allied healthcare professionals. In their
everyday jobs, that is, when delivering care in a normal
non-trial situation, they are expected to abide by a set of
standards clearly defined by their respective professional
bodies (such as the General Medical Council or the
Nursing and Midwifery Council) with regard to their eth-
ical conduct and roles. Some of the professional ethics and
roles of a researcher may appear to be at odds with these.
In the case of the doctor-researcher, conflict may arise
from different care responsibilities imbued by ‘normal’
doctor and researcher roles, whereby the level of care
owed to trial participants differs from that owed to the
doctor’s own patients [21,22]. One way of resolving this
comes from the General Medical Council’s guidance for
Good Medical Practice, which, while prioritizing the
protection of research participants’ interests, emphasizes
the need for participation in research for improving care
for future patients and the wider population [23]. A
second approach to resolving the tension borrows from
the legal paradigm of ‘bailment’: a contractual agreement,
whereby the custody of a patient’s care is temporarily
transferred to the doctor-researcher, while remaining the
overall responsibility of the patient’s usual doctor, allowing
doctor-researchers to focus on the researcher side of their
dual role [21,22]. While these approaches may help
resolve conflict in theory, in practice, doctor-researchers
have revealed unease and mixed understandings of the
meaning of care in the trial context. For example, doctor-
researchers have reported compensating for the altered
duty of care by giving trial participants more attention and
psychological support than expected in a usual clinical
situation [22].
A similar role conflict can arise from the distinction
between the set of values required for research and those
required for nursing and midwifery, particularly pertain-
ing to the consequences of research participation on
confidentiality and trust in the nurse-patient relationship
[24-26]. Unlike doctor-researchers, who may be more
involved in the initiation and running of research trials,
in the RCT context, research nurses are more likely to
be involved in measuring, monitoring and caring for trial
participants. Thus, their personal investment in the
research question, and the importance they place on it,
may also differ.
Eborall et al. Trials 2014, 15:15 Page 3 of 9
http://www.trialsjournal.com/content/15/1/15Randomized controlled trials of behavioural interven-
tions, that is, educational or therapeutic interventions
directed at behavioural or cognitive change, present
fundamental differences from pharmacological or surgical
RCTs, and raise different conflicts for personnel involved.
On the one hand, the absence of pharmaceuticals, surgery
or other medical treatment, may raise fewer concerns
(for personnel) about potential adverse consequences
of random allocation to a particular trial arm. On the
other hand, conflict may arise from the requirement
to deliver an intervention in an unbiased fashion
while holding personal views about the research ques-
tion. Such a conflict could potentially impact on the
outcome of the trial through (intentional or uninten-
tional) lack of fidelity in delivery of the intervention,
perhaps by undermining the principle of equipoise.
Equipoise and associated conflict
A central factor in the role conflicts discussed is the
issue of a researcher’s personal views about, and
emotional and intellectual investment in, the specific
research question and trial. Not being in individual
equipoise about the specific research question can
impact on involvement in the trial in the first place,
willingness to recruit patients, communication with
patient participants, and delivery of the intervention
[8,9,27,28]. Previous research has focused largely on the
first two of these. For example, a study of clinicians
recruiting to neonatal trials revealed that a lack of equi-
poise had a mixed impact on their comfort with recruit-
ment. Some stated that they felt a moral obligation that
they would not be able to take part if not in individual
equipoise, whereas other (more experienced) clinicians
recognized the need to accept collective or community
equipoise, if evidence did not support their own personal
view that one drug worked better than another [8].
A lack of equipoise might indeed raise clinicians’ inter-
est in a trial. In a study of surgeons involved in a trial of
invasive urodynamic testing, most were not in individual
equipoise, as they believed in the benefits of the testing.
Moreover, there was little evidence of community equi-
poise, that is, there was neither a majority of individuals
reportedly undecided on the issue, nor a balance be-
tween those who regarded the treatment as beneficial
and those who did not, as the majority considered it
necessary [27]. However, the lack of evidence from trials
at that point constituted formal community equipoise,
and most surgeons interviewed recognized this. They
were therefore willing to suspend the lack of either
individual equipoise or informal community equipoise,
and randomize their patients into such trials, with the
intention that the results could provide the missing
evidence that, they expected, would support their view
and change others’ practice [27].When involved in recruiting participants, researchers’
personal views can be unambiguous and influence
potential participants’ decisions about participating (for
example, see [7]), but little is known about the impact
during intervention delivery. Useful insight comes from
a study of research nurses involved in a trial comparing
different ways of initiating intensive insulin therapy [28].
Nurses described their dilemma when the protocol
required them to deliver different care from their usual
practice, and prevented them from using their experi-
ence to provide individualized care. They queried the
quality of the data informing the trial, and the lack of
individual equipoise led some (particularly the more
experienced nurses) to deviate from the trial protocol [28].
In this article, we explore the views and experiences of
deliverers of a structured education intervention to
people with type 2 diabetes incorporating training in
either SMBG or self-monitoring of urine glucose (SMUG),
as two arms of a RCT. Of particular interest, in this con-
tentious area, was whether these intervention deliverers
considered themselves to be in equipoise or not and, if
not, how they felt this impacted upon their delivery.
Methods
Background: the DESMOND SMBG RCT
The DESMOND SMBG RCT (full title: ‘Does self-
monitoring of blood glucose as opposed to urinalysis
provide additional benefit to newly diagnosed individuals
with type 2 diabetes receiving structured education?’;
Trial registration: ISRCTN95696668) was a multi-site
cluster RCT. It aimed to compare two self-monitoring
strategies for people with newly diagnosed type 2
diabetes while controlling for the type and degree of
education received [29]. Primarily, it aimed to ascertain
whether there are equivalent changes in glycaemic
control in participants allocated to SMBG or SMUG
over 18 months when incorporated as an integral part of
a comprehensive self-management structured education
programme [30]. Full details of the intervention have
been published in the RCT protocol paper [29].
The RCT was conducted in primary care in seven
Primary Care Trusts (PCTs): public authorities in England
which, at the time of this study, had responsibility for
funding NHS services in a defined geographical area [31].
Participating PCTs needed to (a) be willing to cover
prescribing costs for the strips required for the SMBG
arm upfront (they were reimbursed at the end of the
study), and (b) have a team of accredited DESMOND
educators who were willing to participate. The PCTs and
the educators within each PCT were therefore approached
simultaneously. Within each PCT, participating practices
were cluster-randomized, meaning that all enrolled partic-
ipants in one practice were randomized to one arm of the
trial, in order to avoid potential contamination. Practice
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type 2 diabetes and interested in participating to the local
DESMOND team, who then checked willingness to
participate and booked individuals onto a programme;
educators were not usually involved in recruitment [29].
Educators were trained to deliver both variants of the
study intervention, that is, the standard DESMOND
programme with additional sessions on SMBG or SMUG.
Full details of the trial and development of the interven-
tions have been published [29]. The trial is due to report
its findings in 2014.
In anticipation of the potential for educators to modify
the intervention as specified during delivery, the RCT
design incorporated specific educator training covering:
evidence-based medicine, current evidence about self-
monitoring, and the concept of equipoise. One element,
‘the ribbon task’, based on a bidirectional linear scale,
[32] invited educators to indicate their preferences by
choosing where to stand along a ribbon on the floor
with the words ‘SMBG’ and ‘SMUG’ at each end and
‘neutral’ in the middle. Educators were invited to under-
take this task individually and in a group setting on
three occasions: before and after training, and one year
later at a feedback session. Altogether, the training
aimed to raise educators’ awareness of their own prefer-
ences and the potential impact of these on their delivery
of the intervention, and equipped them with skills to
prevent such an impact. Crucially, training was not
designed to achieve a position where every educator was
in individual equipoise regarding self-monitoring; rather,
the focus was on educators exploring and acknowledging
their personal preferences and their potential impact
[29]. Finally, all educators had already been observed
and assessed by DESMOND trainers as part of the
standard DESMOND quality development system, in
order to become accredited [33]. In addition, and in
order to assess their fidelity to the intervention in the
RCT, educators were observed and assessed delivering
the additional sessions on SMBG or SMUG [29].
Qualitative study with DESMOND educators
Ethical approval for this qualitative work was received (as
part of approval for the RCT) from the Cambridgeshire
Research Ethics Committee (07/H0304/129), and local
research governance approval was obtained from partici-
pating PCTs.
All educators involved in the DESMOND SMBG RCT
were invited to participate in focus group discussions
and interviews held at different time points during the
RCT. At each phase the invitation to participate was
accompanied by information about the qualitative study.
Phase 1: Focus group sessions were conducted at the
beginning (part 1) and end (part 2) of two RCT training
sessions. Phase 2: Follow-up focus group sessions wereconducted at a feedback and training day approximately
1 year into the RCT (once educators had experience of
delivering the interventions). All focus group sessions
were 50 to 60 minutes long. Phase 3: Educators were
invited to participate in a follow-up semi-structured
individual telephone interview approximately 2 years
after initial training. In phase 3, individual interviews
were preferable to focus group discussions both because
of the type of data of interest at this point, more in-depth
reflections, and because it was convenient for the educa-
tors. Telephone interviews were 20 to 45 minutes long.
Flexible topic guides were used in the focus groups
and interviews. Topics included: self-monitoring for type
2 diabetes, generally; the use of SMBG and SMUG,
specifically; the RCT; reflections on the training; and
experiences of delivering the interventions as part of the
RCT. This paper draws on data generated across these
themes, by exploring educators’ views pre-, mid- and
post-delivery of the intervention, and focusing on
whether they considered themselves to be equipoise or
not, and why.
Informed consent was obtained prior to participation
at each phase of the qualitative study. All focus groups
and interviews were audio-recorded, transcribed and
anonymized. Owing to anonymization, we were unable
to compare educators’ individual views across all time
points. Analysis was informed by the constant compara-
tive approach [34]. Transcripts of phase 1 focus groups
were read carefully, in order to develop preliminary
codes, which were categorized into an initial coding
framework and informed the development of the phase
2 topic guide. Transcripts of phase 2 focus groups were
read carefully, in order to develop existing codes further
and add new codes, and to inform the development of
the phase 3 topic guide. The coding framework was
finalized after phase 3; NVivo (QSR International) soft-
ware was used to facilitate systematic coding of all data.
Results
All 23 educators involved in the RCT participated in at
least one phase of the qualitative study. All educators
who attended one of the first two RCT training sessions
(N = 18) agreed to participate in phase 1. All educators
who attended the feedback day (N = 14) agreed to
participate in phase 2 (9 of these had participated in
phase 1). Seven educators agreed to participate in phase
3 (all of these had participated in at least one of the pre-
vious phases). Educators had a range of professional back-
grounds (including: diabetes specialist nurse, dietician,
podiatrist and practice nurse); all but one were female.
Pre-RCT: lack of individual equipoise
Data from the phase 1 focus groups clearly demon-
strated that educators held opinions about the two self-
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threads running through educators’ discussions. First,
the majority expressed a preference for SMBG, owing to
its perceived accuracy, particularly compared with
SMUG, which was seen as outdated. Second, there was
acknowledgement that SMUG could be more appropri-
ate in particular cases, for example, owing to its less
technical nature, so it should not be ruled out altogether.
Hence, the third and most dominant thread was an over-
whelming preference to be able to allocate monitoring
method on an individual basis according to each
patient’s needs. Most qualified their opinions by refer-
ring to years of experience of working in diabetes care.
The following extract is a typical example of how these
first three threads were vocalized:
B2: …It depends on the patient really… I guess, as
health professionals we’re used to dealing with
[SMBG] now so probably more familiar with the use
of that kind of system, how useful it can be; and if you
want good, accurate results that are timely, if done
the right way, then I guess blood glucose monitoring
probably has the advantage. But it’s not for everybody,
by any means, especially with diabetes type 2. It’s very
hard to say which side of the fence I’m on…B3: …If you’ve been around for a long time, you’ve
seen urine testing come and go, seen it superseded by
blood testing, and this is all well and wonderful [but]
it feels like a backwards step sometimes…B1: …We’ve flagged up times when it might be
appropriate to recommend urine testing to people,
which is something we’re not used to doing; and it
wasn’t feeling like a backwards step but like another
useful tool that could be used. (Phase 1, FG2, part 1)
However, a caveat to these views (and the fourth
thread) was that appropriate training for patients, for
example, through DESMOND, was required in how to
use either method effectively, as demonstrated:
A4: I feel that the most important thing is that they’re
educated to know what to do with the information,
with their monitor, whether it be urine testing or
blood glucose monitoring. They need to know what
they should do with that information, to manage their
diabetes. (Phase 1, FG1, part1)
Of more importance than the content of educators’
preferences was the evidence that they could not be
considered to be in individual equipoise. Given their
frontline role in delivering the intervention in the RCT,
and their potential influence on its outcome, thispresented a potential problem. Indeed, a couple of
educators expressed concern that the allocation of
participants to monitoring method required by the RCT
might mean that some would be allocated to a method
that would not suit them:
A2: …Some people are right for urine and some
people are right for blood… and we’ve got our
preconceived ideas [about] which… so are these
people split down the middle…? (Phase 1, FG1, part 1)
Most educators reported that the RCT training had
allowed them to discuss such concerns. The session about
preferences and equipoise was reported as particularly
useful; educators reflected on how the ‘ribbon task’ had
raised their awareness of holding preferences, and had
helped them realize the origins of their own views:
A5: I’ve had those views for a number of years, so it
was nice to know from listening to everybody else
why I felt those views ’cause you forget… they’re just
there, aren’t they? (Phase 1, FG1, part 2)
The training appeared to have met the RCT team’s
aim of conveying the importance to educators of
concealing personal preferences during delivery:
B1: I don’t think my [preference] has changed
but I think what it’s done has enhanced my
awareness of not allowing those beliefs to
impact on [my delivery]. (Phase 1, FG 2, part 2)
RCT delivery: working to conceal preferences
In phase 1, educators expressed confidence in their ability
to deliver both arms of the intervention without bias des-
pite holding preferences or other concerns. Two factors
helped facilitate this. First, the empowerment-based na-
ture of the DESMOND programme meant that educators
should never be didactic; rather by exploring participants’
views, they facilitate the development of self-management
practice [30]. Second, distinguishing between one’s pro-
fessional and one’s personal self helped reconcile the di-
lemma raised by awareness of personal preferences. The
following extract demonstrates both factors:
B2: I would agree with that message that it’s OK to
have an opinion; it doesn’t matter what that opinion
is, as long as you don’t allow it into the study or when
you’re in contact with a group.B1: I think in true DESMOND style that shouldn’t
happen; it should be how you’re thinking anyway,
shouldn’t it? People are going to make their own
decisions.
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personal head and that made me think about that.
I hadn’t thought of that before because I would say
with my professional head on I was fairly neutral but
then actually when I started talking about it, actually
no; inside me I would prefer to be one or the other.
But you recognize that as a professional you need
to be more neutral. (Phase 1, FG2, part 2)
Indeed, in phases 2 and 3 when reflecting on their
delivery, educators indicated how they drew upon
their experience of professionalism (for example, from
years of nursing) in order to help conceal their per-
sonal views:
E21: I think as a nurse you’ve always had to do
things perhaps that you don’t want to do or don’t
fancy doing so it’s part of your training… I’ve gotta
do this, I’ve gotta put a smile on my face…E16: I think it’s really dangerous and if people sort
of approach a patient and bring their own
negativity to that conversation and you can
influence people in that way, so I think with
experience and years of practice… you do tend to
adapt and you do try to portray a very positive,
very neutral… (Phase 2, FG1)
However, others acknowledged the hard mental work
often involved in unbiased delivery. For example, some
with a preference for SMBG reported the effort required
to stay positive when participants allocated to SMUG
returned to the second session having tried the method
for a week with no success:
E5: I think delivering [SMUG] generally is harder…
and you’re having to find resources within yourself to
sort of teach it properly… because… they’re all
coming back [testing] negative. So you’ve got to try
and lead them to the point where they think yeah
okay the urine’s negative but that doesn’t necessarily
mean that my blood sugar’s normal and sometimes it’s
hard to do that as a… you know, you really, really
have to think about it. (Phase 2, FG2)
One reported frustration at not being able to train
participants in the method that they believed would have
suited them:
E2: There were moments when I thought a couple of
members… were at a stage where they could have
benefited from blood glucose testing… but that was
just my own thoughts and I didn’t actually say to
them… (Phase 3)A couple of educators reported dealing with this situ-
ation by reminding themselves of the RCT protocol
provision that participants could swap methods at the
end of (or during) the RCT, if they struggled with their
allocated monitoring method. In contrast, some educa-
tors reported finding their less preferred method easier
to deliver; teaching SMUG was reported as less technical
and less anxiety-inducing for participants who were
worried about finger pricking.
E1: [Teaching SMUG] is so much easier practically…
’cause it took sort of takes less time. It took a lot of
time to actually teach a group of people [SMBG].
(Phase 3)
Commitment to non-biased delivery
Educators’ commitment to delivering the two arms with
fidelity was highly salient throughout the data. When
exploring this commitment further, several linked expla-
nations emerged. First, many reported the importance of
getting an evidence-based answer to a contentious issue;
some mentioned their excitement at being involved with
a trial that would provide such evidence.
E1: I think it’s a really important area. I do, and as far
as, you know, we felt pleased that we could be part of
it. There are so many papers written and whoever
you’re talking to can come up with a different
argument. That has never been done… as part of an
education programme. (Phase 3)
There was a clear sense that educators felt there was a
lot resting on the outcome of the RCT, most notably in
terms of the potential influence on the prescribing
decisions of the PCTs, which were referred to as having
the final say regarding funding SMBG strips.
A5: At the end of the day, it’s driven by the PCT,
isn’t it? The PCT say, ‘No,’ and therefore nobody
gets it. (Phase 1, FG 1, part 1)E2: I’ve already had two people from the
commissioning board saying we’re waiting for
[the results of] the DESMOND SMBG trial. (Phase 3)
Indeed some indicated their desire to communicate
the findings to their PCT personally, if indeed the results
support recommendation of SMBG:
E5: …and then can we go back to our
Medicines Management people and say,
‘Right, we’ve got this piece of research and
this shows that outcomes are better.’?
(Phase 2, FG 2)
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the wider context; a key driver behind their views was
that educators were keen to learn the results themselves
to inform them how to provide the best care to future
patients.
E6: At the end of the day, we want to know… actually
which is the best for patients. So you know we’ve got
to be impartial, I suppose, in terms of how we come
across with patients. (Phase 2, FG1)
Discussion
This paper demonstrates that educators in the DES-
MOND SMBG RCT did hold preferences and opinions
relating to (the two variants of ) the intervention; they
could not therefore be considered to be in individual
equipoise. Training on evidence, equipoise and unbiased
delivery raised educators’ awareness of personal prefer-
ences and the potential for these to impact on delivery.
Educators were confident that they had achieved un-
biased delivery, but acknowledged the challenges
involved. Their perceived ability to conceal their own
preferences was helped by a strong sense of professional-
ism, the patient-centred nature of the DESMOND
programme, and concessions in the RCT protocol. Edu-
cators’ explanations for their commitment to unbiased
delivery included a desire for evidence-based knowledge
in this contentious area, to inform both local healthcare
commissioners and their own future practice with
patients.
It is not surprising that educators had personal opin-
ions about the intervention variants; years of training,
professional socialization and experience of working
with individual patients with diabetes will have informed
their views about effective management of the condition.
However, awareness of the ongoing and contentious
debate for and against the value of SMBG for people
with type 2 diabetes meant that they understood that
community equipoise existed, and thus recognized the
need for evidence to answer this question. Furthermore,
rather than this contentiousness and educators’ own
views exacerbating the tensions arising from having to
deliver both variants, it appears that these contributed to
reinforcing educators’ views about the importance of
neutral delivery.
The educators had not been involved in designing the
RCT; their role was delivering the intervention according
to the protocol. Previous research on role conflict and
equipoise would therefore predict a possible dilemma in
delivering the intervention based on random allocation,
rather than on patient or educator choice [8,28]. Our data
support this to an extent by demonstrating some edu-
cators’ frustration at not being able to tailor care to
individual patient’s needs. However, contrary to previousresearch, educators reported confidence that they had not
only adhered to protocol, but expressed a strong commit-
ment to concealing their personal views, to ensure proper
conduct in the RCT and thus produce much-needed evi-
dence. Our data thus supports Hilton et al.’s argument
[27] that believing in community equipoise can be suffi-
cient in suspending one’s own individual equipoise. The
surgeons in Hilton et al.’s study, however, were convinced
of the validity of their own views and thus regarded the
RCT as a vehicle for providing evidence to persuade
the community at large of their opinion [27]. In
contrast, the educators in our study appeared to be
genuinely keen for the RCT to provide an evidence-
based answer to the question, whatever the outcome,
enabling them to deliver evidence-based care to their
own future patients. Furthermore, in the event that
the evidence supported recommending SMBG to this
patient group, they anticipated also using the evidence
to help persuade those in control of funding decisions
in their PCTs.
The strong sense of professionalism and commitment
indicated by educators when describing working to
conceal their personal preferences echoes the idea of
‘active’ or ‘responsible’ uncertainty as a way of making
sense of community equipoise, when not in individual
equipoise [8]. Seeing the requirement to balance benefit
against harm and engage with expert knowledge as part
of one’s professional duty [8] appeared to help educators
reconcile any distinctions between the values of the dual
nurse-researcher role. Further, rather than educators’
professionalism from years of being a nurse (or other
healthcare professional) leading to role conflict in the
research situation, [22,24-26], educators appeared to
draw upon professionalism as a useful resource in man-
aging any tensions and their lack of individual equipoise.
This study was limited by an opt-in sample, and not
all of the educators involved in phase 1 and 2 replied
when invited for interview in phase 3. However, the data
demonstrate that our sample held a complete range of
views about the intervention variants. Furthermore, the
prospective nature of the design allowed us to scrutinize
views before and after educators had delivered the inter-
vention variants in the trial. We acknowledge that the
data are limited to educators’ reports of behaviour. Thus,
we can only treat educators’ reports of unbiased delivery
at face value. Educators’ delivery was, however, observed
on at least one occasion by DESMOND trainers as part
of the standard quality development process for all
DESMOND educators [35].
Implications
The finding that educators’ commitment to unbiased
delivery was influenced by their desire for an evidence-
based answer to an important question will be of interest
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deliverers ‘buying into’ the purpose of research high-
lights the value in training them in: the concept of
equipoise, the potential impact of their preferences on
the outcome of an RCT, the current state of community
equipoise regarding the particular research question and
the need for evidence. As discussed by others, the term
‘equipoise’ itself could help in such training of those less
experienced in RCTs, by strengthening views and under-
standings of the challenging RCT situation; as the term
is rarely used in everyday talk, it is less likely to cause
confusion than words such as ‘uncertainty’ and ‘trial’,
which may have several meanings outside the trial
setting [7]. A key part of the training session in the
current study was the emphasis that it was not aiming
to convert each educator to a position of individual equi-
poise. Rather, the focus was on facilitating educators’
awareness of their individual views and their potential
for these to impact intervention delivery, and providing
them with the skills needed to prevent such an impact.
Indeed integral to this was reassuring educators that not
being in individual equipoise was acceptable, and that
what mattered was awareness of one’s own preferences
when in contact with participants. Our findings show
that this approach was successful in raising the salience
of the issue for deliverers, and suggest that it provided
them with a useful resource in managing their own lack
of equipoise when delivering the intervention. These are
relevant and encouraging findings not just for those
delivering an intervention in the RCT context, but for all
personnel who have contact with participants, from the
recruitment process through to trial closure.Conclusions
This study provides insight into a new group of
personnel in the area of research on trial participation:
deliverers of behavioural (educational) interventions.
Rather than individual equipoise, intervention deliverers’
awareness of personal preferences and their potential
impact on the trial outcome appeared to facilitate un-
biased delivery if the intervention variants. Further, aware-
ness of community equipoise, the need for evidence, and
personal and professional relevance of the research area,
enhanced deliverers’ reported commitment to the RCT.
Incorporating training in these aspects can enhance deliv-
erers’ commitment to the RCT and thus concealment of
preferences during delivery.Ethical approval
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